P Spx: Cannabis Regulation and Dow Jones

p spx: Chinese exports unexpectedly fell 2.7% in April, creating further concerns about the state of the global economy, according to Market Watch. For more, read Dow threatens longest losing skid in 2 months amid U.S.-China trade tensions In news on cannabis regulation, a congressional committee has canceled planned votes on two bills relating to medical cannabis for army veterans and will hold a later hearing instead, as reported by website Marijuana Moment. The Dow Jones Industrial Average DJIA, 0.44% and S&P 500 SPX, 0.37% fell before reversing their losses, after the U.S. government said it is increasing tariffs on about 200 billion of Chinese goods to 25% from 10%. Adding to the gloom was the news that Iran may cease compliance with parts of a 2015 nuclear deal signed with the U.S., Britain, France, Germany, China and Russia. One of the bills proposed allowing U.S. Department of Veterans Affairs doctors recommend medical cannabis in states that have legalized without losing their VA benefits. Among individual companies, Cronos Group Inc. shares CRON, 9.30%CRON, 8.40% fell 2%, a day after the company announced the opening of a new research and development center in Israel that will focus on next-generation vaporizer products. The second proposed allowing the VA to move ahead with clinical trials evaluating the benefit of cannabis in treating conditions, including post-traumatic stress disorder and chronic pain. (news.financializer.com). As reported in the news.

The content, information, trademarks and multimedia posted on this blog copyrights to their original owners and herein blogged in good faith for the purpose of commentary, speech, opinion and debate.

financializer news

A weblog highlighting financial topics making news in the international media.